RocA Truncation Underpins Hyper-Encapsulation, Carriage Longevity and Transmissibility of Serotype M18 Group A Streptococci

PLoS Pathogens

Volumn 9, Issue 12, 2013, Pages 1-15

  Lynskey, Nicola N ^a   Goulding, David ^b   Gierula, Magdalena ^a   Turner, Claire E ^a   Dougan, Gordon ^b   Edwards, Robert J ^a   Sriskandan, Shiranee ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; PROTEOME; REGULATOR PROTEIN; ROCA PROTEIN; UNCLASSIFIED DRUG; ROCA PROTEIN, STREPTOCOCCUS PYOGENES; TRANSACTIVATOR PROTEIN;

ARTICLE; BACTERIUM CARRIER; CONTROLLED STUDY; DISEASE TRANSMISSION; DNA SEQUENCE; ENCAPSULATION; LONGEVITY; MUTAGENESIS; NASOPHARYNX; NONHUMAN; PHAGOCYTOSIS; PHARYNGITIS; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; SEROTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; STREPTOCOCCUS GROUP A; AMINO ACID SEQUENCE; ANIMAL; BACTERIAL SPORE; CELL CULTURE; CLASSIFICATION; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIAL VIABILITY; MICROBIOLOGY; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; RESPIRATORY TRACT INFECTION; SEROTYPING; STOP CODON; STREPTOCOCCUS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELLS, CULTURED; CODON, NONSENSE; FEMALE; HUMANS; MICE; MICROBIAL VIABILITY; MOLECULAR SEQUENCE DATA; NASOPHARYNX; RESPIRATORY TRACT INFECTIONS; SEROTYPING; SPORES, BACTERIAL; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; STREPTOCOCCUS PYOGENES; TRANS-ACTIVATORS;

EID: 84892851667     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003842     Document Type: Article

References (49)

1. Courtney HS, Hasty DL, (2002) Dale JB, (2002) Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci. Ann Med 34: 77-87.
2. Wessels MR, Moses AE, Goldberg JB, DiCesare TJ, (1991) Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc Natl Acad Sci 88: 8317-8321.
3. Wessels MR, Bronze MS, (1994) Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. Proc Natl Acad Sci 91: 12238-12242.
4. Cywes C, Stamenkovic I, Wessels MR, (2000) CD44 as a receptor for colonization of the pharynx by group A Streptococcus. J Clin Invest 106: 995-1002.
5. Cywes C, Wessels MR, (2001) Group A Streptococcus tissue invasion by CD44-mediated cell signaling. Nature 414: 648-652.
6. Smoot JC, Korgenski EK, Daly JA, Veasy LG, Musser JM, (2002) Molecular analysis of group A Streptococcus type emm18 isolates temporally associated with acute rheumatic fever outbreaks in Salt Lake City, Utah. J Clin Microbiol 40: 1805-1810.
7. Smoot JC, Barbian KD, Van Gompel JJ, Smoot LM, Chaussee MS, et al. (2002) Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci 99: 4668-4673.
8. Johnson D, Stevens DL, Kaplan EL, (1992) Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 30: 374.
9. Veasy LG, Tani LY, Daly JA, Korgenski K, Mine L, et al. (2004) Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 113: e168-e172.
10. Veasy LG, Wiedmeier SE, Orsmond GS, Ruttenberg HD, Boucek MM, et al. (1987) Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 316: 421-427.
11. Ellis NM, Kurahara DK, Vohra H, Mascaro-Blanco A, Erdem G, et al. (2010) Priming the immune system for heart disease: a perspective on group A streptococci. J Infect Dis 202: 1059-1067.
12. Alberti S, Ashbaugh CD, Wessels MR, (1998) Structure of the has operon promoter and regulation of hyaluronic acid capsule expression in group A Streptococcus. Mol Microbiol 28: 343-353.
13. Graham MR, Smoot LM, Migliaccio CA, Virtaneva K, Sturdevant DE, et al. (2002) Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc Natl Acad Sci 99: 13855-13860.
14. van der Rijn I, Drake RR, (1992) Analysis of the streptococcal hyaluronic acid synthase complex using the photoaffinity probe 5-azido-UDP-glucuronic acid. J Biol Chem 267: 24302-24306.
15. Blank LM, Hugenholtz P, Nielsen LK, (2008) Evolution of the hyaluronic acid synthesis (has) operon in Streptococcus zooepidemicus and other pathogenic streptococci. J Mol Evol 67: 13-22.
16. Flores AR, Jewell BE, Fittipaldi N, Beres SB, Musser JM, (2012) Human disease isolates of serotype M4 and M22 group A streptococcus lack genes required for hyaluronic acid capsule biosynthesis. mBio 3 (6):: e00413-12.
17. Cho KH, Caparon MG, (2005) Patterns of virulence gene expression differ between biofilm and tissue communities of Streptococcus pyogenes. Mol Microbiol 2005 Sep;57 (6):: 1545-56.
18. Browning DF, Busby SJ, (2004) The regulation of bacterial transcription initiation. Nat Rev Microbiol 2: 57-65.
19. Caparon MG, Geist RT, Perez-Casal J, Scott JR, (1992) Environmental regulation of virulence in group A streptococci: transcription of the gene encoding M protein is stimulated by carbon dioxide. J Bacteriol 174: 5693-5701.
20. Graham MR, Virtaneva K, Porcella SF, Barry WT, Gowen BB, et al. (2005) Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies. Am J Pathol 166: 455-465.
21. Hynes W, (2004) Virulence factors of the group A streptococci and genes that regulate their expression. Front Biosci 9: 3399-3433.
22. Kreikemeyer B, McIver KS, Podbielski A, (2003) Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions. Trends Microbiol 11: 224-232.
23. Pritchard KH, Cleary PP, (1996) Differential expression of genes in the vir regulon of Streptococcus pyogenes is controlled by transcription termination. Mol Gen Genet 250: 207-213.
24. Sumby P, Whitney AR, Graviss EA, DeLeo FR, Musser JM, (2006) Genome-wide analysis of group A streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog 2: e5.
25. Heath A, DiRita VJ, Barg NL, Engleberg NC, (1999) A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infect Immun 67: 5298-5305.
26. Walker MJ, Hollands A, Sanderson-Smith ML, Cole JN, Kirk JK, et al. (2007) DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med 13: 981-985.
27. Turner CE, Kurupati P, Jones MD, Edwards RJ, Sriskandan S, (2009) Emerging role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes Infection. J Infect Dis 200: 555-563.
28. Biswas I, Scott JR, (2003) Identification of rocA, a positive regulator of covR expression in the group A streptococcus. J Bacteriol 185: 3081-3090.
29. Levin JC, Wessels MR, (1998) Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus. Mol Microbiol 30: 209-219.
30. Treviño J, Perez N, Ramirez-Peña E, Liu Z, Shelburne SA 3rd, et al. (2009) CovS simultaneously activates and inhibits the CovR-mediated repression of distinct subsets of group A Streptococcus virulence factor-encoding genes. Infect Immun 77 (8):: 3141-9.
31. Engleberg NC, Heath A, Miller A, Rivera C, DiRita VJ, (2001) Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J Infect Dis 183: 1043-54.
32. Hollands A, Pence MA, Timmer AM, Osvath SR, Turnbull L, et al. (2010) Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone. J Infect Dis 202 (1):: 11-9.
33. Barnett TC, Bugrysheva JV, Scott JR, (2007) Role of mRNA stability in growth phase regulation of gene expression in the group A streptococcus. J Bacteriol 189 (5):: 1866-73.
34. Shelburne SA III, Sumby P, Sitkiewicz I, Granville C, DeLeo FR, et al. (2005) Central role of a bacterial two-component gene regulatory system of previously unknown function in pathogen persistence in human saliva. Proc Natl Acad Sci 102: 16037-16042.
35. Sumby P, Zhang S, Whitney AR, Falugi F, Grandi G, et al. (2008) A chemokine-degrading extracellular protease made by group A Streptococcus alters pathogenesis by enhancing evasion of the innate immune response. Infect Immun 76: 978-985.
36. Sugareva V, Arlt R, Fiedler T, Riani C, Podbielski A, et al. (2010) Serotype- and strain- dependent contribution of the sensor kinase CovS of the CovRS two-component system to Streptococcus pyogenes pathogenesis. BMC Microbiol 10: 34.
37. Chow V, Nong G, Preston JF, (2007) Structure, function, and regulation of the aldouronate utilization gene cluster from Paenibacillus sp. strain JDR-2. J J Bacteriol 189: 8863-8870.
38. Dinkla K, Rohde M, Jansen WT, Kaplan EL, Chhatwal GS, et al. (2003) Rheumatic fever-associated Streptococcus pyogenes isolates aggregate collagen. J Clin Invest 111 (12):: 1905-12.
39. Cortés G, Wessels MR, (2007) Inhibition of dendritic cell maturation by group A Streptococcus. J Infect Dis 2009 Oct 1;200 (7):: 1152-61.
40. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, et al. (2002) Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 7;195 (1):: 99-111.
41. Hollands A, Aziz RK, Kansal R, Kotb M, Nizet V, et al. (2008) A naturally occurring mutation in ropB suppresses SpeB expression and reduces M1T1 group A streptococcal systemic virulence. PLoS One 3 (12):: e4102.
42. Olsen RJ, Sitkiewicz I, Ayeras AA, Gonulal VE, Cantu C, et al. (2010) Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis. Proc Natl Acad Sci U S A 12;107 (2):: 888-93.
43. Alam FM, Turner CE, Smith K, Wiles S, Sriskandan S, (2013) Inactivation of the CovR/S virulence regulator impairs infection in an improved murine model of Streptococcus pyogenes naso-pharyngeal infection. PLoS ONE 8: e61655.
44. Pospiech A, Neumann B, (1995) A versatile quick-prep of genomic DNA from gram-positive bacteria. Trends Genet 11: 217-218.
45. Unnikrishnan M, Cohen J, Sriskandan S, (2001) Complementation of a speA negative Streptococcus pyogenes with speA: effects on virulence and production of streptococcal pyrogenic exotoxin A. Microb Pathog 31: 109-114.
46. Sriskandan S, Unnikrishnan M, Krausz T, Cohen J, (2000) Mitogenic factor (MF) is the major DNase of serotype M89 Streptococcus pyogenes. Microbiology 146 (Pt 11):: 2785-92.
47. Edwards RJ, Wrigley A, Bai Z, Bateman M, Russell H, et al. (2007) C-terminal antibodies (CTAbs): a simple and broadly applicable approach for the rapid generation of protein-specific antibodies with predefined specificity. Proteomics 7: 1364-1372.
48. Zinkernagel AS, Timmer AM, Pence MA, Locke JB, Buchanan JT, et al. (2008) The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing. Cell Host Microbe 14;4 (2):: 170-8.
49. Malick LE, Wilson RB, (1975) Modified thiocarbohydrazide procedure for scanning electron microscopy: routine use for normal, pathological, or experimental tissues. Stain Technol 50: 265-269.